chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lip blister, Lip pain, Loss of personal independence in daily activities, Pain, SARS-CoV-2 test
Clinical narrative: Temp went up to 101; hardly slept; she was unable to work; Whole body aches; Small blister on lower lip; lip soreness; coughing; wheezing; having difficulty breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 62-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 intramuscular on 28Apr2021 09:00 (at the age of 62-Years-old) (Batch/Lot Number: EL3247) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Epicondylitis of arms and knees. Concomitant medication included losartan taken for unspecified indication and folic acid taken for an unspecified indication and Oxtrexup within 2 weeks of vaccination. The patient received first dose of BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1, intramuscular administered in left arm on 07Apr2021 09:00 (at the age of 62-Years-old) (Batch/Lot Number: EL3247) as DOSE 1, SINGLE for covid-19 immunisation. On 29Apr2021, the patient temperature went up to 101, temperature went up to 101 around 3am this morning, down to 100 at 7:46am, for 2 days and body aches, hardly slept and low-grade fever from 99-100 for 5 days. Small blister on lower lip appeared on 2d day after vaccine, coughing and wheezing started on 2nd day after vaccine and still as of today have needed to use nebulizer every day as patient had difficulty breathing. She used Neosporin on lips for blisters on lower lip - not visible now but can still feel lip soreness. As of today, Thursday, May 6, Still coughing and having difficulty breathing and needing to nebulize. Patient took Tylenol and drank fluids, etc. The patient underwent lab tests and procedures which included body temperature and showed 101 Fahrenheit on Mar2021, sars-cov-2 test was negative on Mar2021. Patient did not receive any other vaccines within 4 weeks prior to the COVID. Patient was diagnosed with COVID-19 Prior to vaccination. Patient was not tested for COVID-19, since the vaccination. Therapeutic measures were taken as a result of events. At the time of this report, the outcome of event was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Temp went up to 101; hardly slept; she was unable to work; Whole body aches; Small blister on lower lip; lip soreness; coughing; wheezing; having difficulty breathing; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 62-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 intramuscular on 28Apr2021 09:00 (at the age of 62-Years-old) (Batch/Lot Number: EL3247) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included Epicondylitis of arms and knees. Concomitant medication included losartan taken for unspecified indication and folic acid taken for an unspecified indication and Oxtrexup within 2 weeks of vaccination. The patient received first dose of BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1, intramuscular administered in left arm on 07Apr2021 09:00 (at the age of 62-Years-old) (Batch/Lot Number: EL3247) as DOSE 1, SINGLE for covid-19 immunisation. On 29Apr2021, the patient temperature went up to 101, temperature went up to 101 around 3am this morning, down to 100 at 7:46am, for 2 days and body aches, hardly slept and low-grade fever from 99-100 for 5 days. Small blister on lower lip appeared on 2d day after vaccine, coughing and wheezing started on 2nd day after vaccine and still as of today have needed to use nebulizer every day as patient had difficulty breathing. She used Neosporin on lips for blisters on lower lip - not visible now but can still feel lip soreness. As of today, Thursday, May 6, Still coughing and having difficulty breathing and needing to nebulize. Patient took Tylenol and drank fluids, etc. The patient underwent lab tests and procedures which included body temperature and showed 101 Fahrenheit on Mar2021, sars-cov-2 test was negative on Mar2021. Patient did not receive any other vaccines within 4 weeks prior to the COVID. Patient was diagnosed with COVID-19 Prior to vaccination. Patient was not tested for COVID-19, since the vaccination. Therapeutic measures were taken as a result of events. At the time of this report, the outcome of event was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Chills, Fatigue, Pain
Clinical narrative: Chills; Aches; Temperature of 100.8; Stomach ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 27Apr2021 at 13:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease, and intravenous iodine allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (CRESTOR), metoprolol (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and pregnenolone (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously took alprazolam (XANAX) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 10:00, the patient experienced chills, aches, temperature of 100.8 (units unspecified), stomach ache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, aches, temperature of 100.8 (units unspecified), stomach ache and fatigue was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; Aches; Temperature of 100.8; Stomach ache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 27Apr2021 at 13:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease, and intravenous iodine allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included levothyroxine sodium (SYNTHROID), rosuvastatin calcium (CRESTOR), metoprolol (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and pregnenolone (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously took alprazolam (XANAX) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 05Apr2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 10:00, the patient experienced chills, aches, temperature of 100.8 (units unspecified), stomach ache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, aches, temperature of 100.8 (units unspecified), stomach ache and fatigue was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Muscle spasms
Clinical narrative: The day after "my"vaccine, "i" had a very heavy period. "I" rarely have a heavy period because of the birth control I'm on.; I've had very bad cramps (I have not had these in many many years and have been the worst cramps I've experience).; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 14:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included oral contraceptive nos (MANUFACTURER UNKNOWN), vitamin supplements (MANUFACTURER UNKNOWN) and iron (MANUFACTURER UNKNOWN) all for unknown indication, from an unknown date and unknown if ongoing. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 26Apr2021 at 07:30, the day after the vaccine the patient had a very heavy period. She rarely had a heavy period because of the birth control she was on. She had very bad cramps (she had not had these in many many years and had been the worst cramps she had experienced). The cramps have substantially calmed down and period started to lighten up on 28Apr2021. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events heavy period and cramp was recovering at the time of  this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Oropharyngeal discomfort
Clinical narrative: I immediately had a metal taste in my mouth; The back of my throat started bothering me. I feel like I have to keep clearing my throat.; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 10:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome, latex allergy, and allergy to wool. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included sertraline hydrochloride (ZOLOFT) and omeprazole (PRILOSEC); both from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 10:00, the patient immediately had a metal taste in mouth. The back of her throat started bothering and she felt like she had to keep clearing her throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events immediately had a metal taste in mouth; the back of her throat started bothering and she felt like she had to keep clearing her throat was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Insomnia, Muscle spasms, Pain, Pyrexia
Clinical narrative: High fever; Body aches; Muscles spasms all over body; Muscles spasms all over my body all night that made sleeping difficult.; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, anxiety and allergy to shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 07Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 18:00, the patient experienced high fever, body aches, muscles spasms all over the body all night that made sleeping difficult and severe headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events high fever, body aches, muscles spasms all over body, sleeping difficult and severe headache was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node1 week after vaccination; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 13:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 14Apr2021 at 12:00, the patient experienced swollen lymph node, one week after vaccination which has not changed in two weeks. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node, one week after vaccination was not resolved at the time of the report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Apr2021 as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Chills; Fever; Muscle aches; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 26Apr2021 at 10:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as N/A). The patient did not have any known allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 10:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 02:00, the patient experienced chills, fever, muscle aches and headache. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event chills, fever, muscle aches and headache was resolved on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Fatigue, Headache, Malaise
Clinical narrative: Increase in temperature; Moderate left arm pain; Slight headache; Very fatigued; Feel very sick; This is a spontaneous report from a contactable other healthcare professional, the patient. A 62-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL), acetylsalicylic acid (ASPIRIN) and azithromycin (Z-PAK), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 28Apr2021 at 06:00, the patient experienced increase in temperature, moderate left arm pain, slight headache, very fatigued and felt very sick. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events increase in temperature, moderate left arm pain, slight headache, very fatigued and felt very sick was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Increase in temperature; Moderate left arm pain; Slight headache; Very fatigued; Feel very sick; This is a spontaneous report from a contactable other healthcare professional, the patient. A 62-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL), acetylsalicylic acid (ASPIRIN) and azithromycin (Z-PAK), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 28Apr2021 at 06:00, the patient experienced increase in temperature, moderate left arm pain, slight headache, very fatigued and felt very sick. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events increase in temperature, moderate left arm pain, slight headache, very fatigued and felt very sick was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swollen area between shoulder and neck; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication was not reported. On an unknown date in Apr2021, the patient experienced a swollen area between shoulder and neck. The clinical outcome of the event swollen area between shoulder and neck was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, Vomiting
Clinical narrative: Severe chills; Nauseous; Dizzy; Extremely fatigued, wiped out; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 22Apr2021 at 13:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin calcium (CRESTOR), multivitamin (MANUFACTURER UNKNOWN), and vitamin d nos (VITAMIN D) all for unknown indication from an unknown date and unknown if ongoing. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 about 15 hours after the vaccine the patient developed severe chills for 3 hours, then felt very nauseous, dizzy, and extremely fatigued. This continued for the next few days. For about 24 hours the patient could not even keep water down without vomiting. Symptoms lasted about 36 hours. After 36 hours the patient felt much better, but still felt very wiped out for the next few days. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, nauseous, dizzy, extremely fatigued and vomiting were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Body temperature, Lymphadenopathy, Pain, Pruritus
Clinical narrative: 2 weeks after second does same reaction on stomach and leg but symptoms less severe.; small blisters; the rash is red; itch; hurt; small lessons appeared; Fever of 101; swollen lymph nodes in my neck; This is a spontaneous report from a contactable consumer. A 63-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6204), via intramuscular route, administered in Arm Left on 09Apr2021 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 63 years). Previously patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN-6198) in 12Mar2021.Patient is not pregnant at the time of vaccination. The patient medical history was not reported. There were no concomitant medications. Received no other vaccine in four weeks. No other medications in two weeks. The patient experienced 2 weeks after second does same reaction on stomach and leg but symptoms less severe, small blisters, the rash is red, itch, hurt, small lessons appeared, fever of 101, swollen lymph nodes in my neck on an unspecified date. It was reported that 2 weeks after first does developed rash on thigh which looked and felt like shingles. dot worse for two weeks spreading in the area. painful and itchy. started to resolve after 3 weeks. 2 weeks after second does same reaction on stomach and leg but symptoms less severe. started to resolve after a week. 3 weeks after second dose more small lessons appeared. the rash is red raised with small blisters that itch and hurt. they dried up after 3 weeks. 2 weeks after each vaccine she developed a rash with blisters forming after 5-7 days. The rash lasted approximately 3 weeks each time the blisters started to dry up after 2 weeks the rash got worse for approximately 2 weeks. It itched and was painful incisures (unclear meaning) consistent with shingles virus. 3 weeks after the second vaccine she developed a fever of 101 for 2 days and swollen lymph nodes in my neck which lasted for 3-2 weeks. The adverse event resulted in clinic visit. No covid prior vaccination. Covid tested post vaccination. Covid test type post vaccination was nasal swab. The patient underwent lab tests which included body temperature: 101 No units provided and sars-cov-2 test: negative on 26Apr2021. No treatment received. The clinical outcome of the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Rash erythematous, SARS-CoV-2 test, Skin lesion
Clinical narrative: 2 weeks after second does same reaction on stomach and leg but symptoms less severe.; small blisters; the rash is red; itch; hurt; small lessons appeared; Fever of 101; swollen lymph nodes in my neck; This is a spontaneous report from a contactable consumer. A 63-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6204), via intramuscular route, administered in Arm Left on 09Apr2021 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 63 years). Previously patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN-6198) in 12Mar2021.Patient is not pregnant at the time of vaccination. The patient medical history was not reported. There were no concomitant medications. Received no other vaccine in four weeks. No other medications in two weeks. The patient experienced 2 weeks after second does same reaction on stomach and leg but symptoms less severe, small blisters, the rash is red, itch, hurt, small lessons appeared, fever of 101, swollen lymph nodes in my neck on an unspecified date. It was reported that 2 weeks after first does developed rash on thigh which looked and felt like shingles. dot worse for two weeks spreading in the area. painful and itchy. started to resolve after 3 weeks. 2 weeks after second does same reaction on stomach and leg but symptoms less severe. started to resolve after a week. 3 weeks after second dose more small lessons appeared. the rash is red raised with small blisters that itch and hurt. they dried up after 3 weeks. 2 weeks after each vaccine she developed a rash with blisters forming after 5-7 days. The rash lasted approximately 3 weeks each time the blisters started to dry up after 2 weeks the rash got worse for approximately 2 weeks. It itched and was painful incisures (unclear meaning) consistent with shingles virus. 3 weeks after the second vaccine she developed a fever of 101 for 2 days and swollen lymph nodes in my neck which lasted for 3-2 weeks. The adverse event resulted in clinic visit. No covid prior vaccination. Covid tested post vaccination. Covid test type post vaccination was nasal swab. The patient underwent lab tests which included body temperature: 101 No units provided and sars-cov-2 test: negative on 26Apr2021. No treatment received. The clinical outcome of the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed, Oligomenorrhoea
Clinical narrative: Long cycle/delayed period. Cycle was 40 days long and is usually 32-34 days; Long cycle/delayed period. Cycle was 40 days long and is usually 32-34 days; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 21Apr2021 at 15:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date in Apr2021, the patient experienced long cycle/delayed period, cycle was 40 days long and was usually 32-34 days. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event long cycle/delayed period, cycle was 40 days long and was usually 32-34 days was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: fever and chills; fever and chills; very bad like pain in my arm, in my neck; very bad like pain in my arm, in my neck; This is a spontaneous report from a contactable consumer (patient). A 57-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8737; Expiration Date: 31Jul2021) via an unspecified route of administration, administered in Arm Left on 07Apr2021 (Age at Vaccination 57-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced fever and chills, very bad like pain in my arm, in my neck. It was reported that the first shot I got I had like a fever and chills, very bad like pain in my arm, in my neck from the first shot. The outcome of the events was unknown.  No Follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Heart rate, Hypersomnia
Clinical narrative: Extreme fatigue, unable to open eyes for more than 2 seconds; Slept for 40 hours only waking to use restroom; Fever; Tachypnea 30-35 breaths per minute; Tachycardia of 120 beats per minute; Nausea; Body aches; Headache; This is a spontaneous report from a contactable nurse, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 16Jan2021 at 07:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 19Dec2020 at 07:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 16Jan2021 at 18:00, the patient experienced extreme fatigue and was unable to open eyes for more than 2 seconds. She slept for 40 hours and only woke to use the restroom, fever of 103 despite tylenol, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache. All the symptoms lasted for 24-36 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event fever and included treatment with paracetamol (TYLENOL) from an unknown date. Therapeutic measures were not taken as a result of the events extreme fatigue, unable to open eyes for more than 2 seconds, slept for 40 hours only woke to use restroom, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme fatigue, unable to open eyes for more than 2 seconds, slept for 40 hours only woke to use restroom, fever of 103, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache was resolved on an unknown date in Jan2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Respiratory rate, Tachycardia
Clinical narrative: Extreme fatigue, unable to open eyes for more than 2 seconds; Slept for 40 hours only waking to use restroom; Fever; Tachypnea 30-35 breaths per minute; Tachycardia of 120 beats per minute; Nausea; Body aches; Headache; This is a spontaneous report from a contactable nurse, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 16Jan2021 at 07:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 19Dec2020 at 07:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 16Jan2021 at 18:00, the patient experienced extreme fatigue and was unable to open eyes for more than 2 seconds. She slept for 40 hours and only woke to use the restroom, fever of 103 despite tylenol, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache. All the symptoms lasted for 24-36 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event fever and included treatment with paracetamol (TYLENOL) from an unknown date. Therapeutic measures were not taken as a result of the events extreme fatigue, unable to open eyes for more than 2 seconds, slept for 40 hours only woke to use restroom, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme fatigue, unable to open eyes for more than 2 seconds, slept for 40 hours only woke to use restroom, fever of 103, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache was resolved on an unknown date in Jan2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Tachypnoea
Clinical narrative: Extreme fatigue, unable to open eyes for more than 2 seconds; Slept for 40 hours only waking to use restroom; Fever; Tachypnea 30-35 breaths per minute; Tachycardia of 120 beats per minute; Nausea; Body aches; Headache; This is a spontaneous report from a contactable nurse, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 16Jan2021 at 07:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 19Dec2020 at 07:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. On 16Jan2021 at 18:00, the patient experienced extreme fatigue and was unable to open eyes for more than 2 seconds. She slept for 40 hours and only woke to use the restroom, fever of 103 despite tylenol, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache. All the symptoms lasted for 24-36 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event fever and included treatment with paracetamol (TYLENOL) from an unknown date. Therapeutic measures were not taken as a result of the events extreme fatigue, unable to open eyes for more than 2 seconds, slept for 40 hours only woke to use restroom, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme fatigue, unable to open eyes for more than 2 seconds, slept for 40 hours only woke to use restroom, fever of 103, tachypnoea 30-35 breaths per minute, tachycardia of 120 beats per minute, nausea, body aches and headache was resolved on an unknown date in Jan2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Body aches; Extreme fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 26Apr2021 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to dairy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on an unknown date (at unspecified age) as a single dose for COVID-19 immunisation.  On 27Apr2021, the patient experienced body aches and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches and extreme fatigue were resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lymphadenitis, Myalgia, Pelvic pain
Clinical narrative: Lymph nodes inflammation in groin left area; muscle pain in left arm and breast; pelvic pain; joint pain; headache; This is a spontaneous report from a contactable consumer (patient). A 26-years-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 11:15 (at the age of 26-years-old) (Batch/Lot Number: ER8729) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced lymph nodes inflammation in groin left area, muscle pain in left arm and breast, pelvic pain, joint pain and headache on 23Apr2021 12:00. Events resulted in visit to the doctor's office. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. Device date was reported as 04May2021. Patient received no treatment for the events. Seriousness of events were reported as non serious by the reporter. Outcome of all events were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Diarrhoea, Dizziness, Headache
Clinical narrative: Aches at injection site as well as joints, particularly in shoulders.; Aches at injection site as well as joints, particularly in shoulders.; Warm almost burning sensation left foot; Dizziness; Diarrhea; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left  arm on 24Apr2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced aches at injection site as well as joints, particularly in shoulders, warm almost burning sensation left foot that subsided after about an hour of walking around, dizziness, diarrhea and headaches persisting through the following day. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches at injection site as well as joints particularly in shoulders were unknown, while the clinical outcome of the event warm almost burning sensation left foot was resolved on an unknown date in Apr2021. The clinical outcome of the events dizziness, diarrhea and headaches were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Aches at injection site as well as joints, particularly in shoulders.; Aches at injection site as well as joints, particularly in shoulders.; Warm almost burning sensation left foot; Dizziness; Diarrhea; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left  arm on 24Apr2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced aches at injection site as well as joints, particularly in shoulders, warm almost burning sensation left foot that subsided after about an hour of walking around, dizziness, diarrhea and headaches persisting through the following day. The patient did not receive any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches at injection site as well as joints particularly in shoulders were unknown, while the clinical outcome of the event warm almost burning sensation left foot was resolved on an unknown date in Apr2021. The clinical outcome of the events dizziness, diarrhea and headaches were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.